XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-01-12
DOI
https://doi.org/10.3389/fimmu.2025.1672725
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial

M. Liu, P. Zhang, Jing Wei, Lin Zhu et al.
Frontiers in Immunology
Esophageal Cancer Research and Treatment
article

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial

M. Liu, P. Zhang, Jing Wei, Lin Zhu, Mo Cheng, W. Li, Menghui Xu, Sihui Song, Dan Li, Cheng Huang
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
Sichuan University (CN), West China Hospital of Sichuan University (CN), Sichuan Cancer Hospital (CN)
Sichuan University, West China Hospital, Sichuan University
Good health and well-being
Openalex Percentile: Top 91%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial — M. Liu, P. Zhang, et al. · Frontiers in Immunology (2026) | TGRS Research Map | TGRS